» Articles » PMID: 30761461

The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis

Overview
Specialty Pharmacology
Date 2019 Feb 15
PMID 30761461
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Value of information (VOI) analysis quantifies the opportunity cost associated with decision uncertainty, and thus informs the value of collecting further information to avoid this cost. VOI can inform study design, optimal sample size selection, and research prioritization. Recent methodological advances have reduced the computational burden of conducting VOI analysis and have made it easier to evaluate the expected value of sample information, the expected net benefit of sampling, and the optimal sample size of a study design ([Formula: see text]). The volume of VOI analyses being published is increasing, and there is now a need for VOI studies to conduct sensitivity analyses on VOI-specific parameters. In this practical application, we introduce the curve of optimal sample size (COSS), which is a graphical representation of [Formula: see text] over a range of willingness-to-pay thresholds and VOI parameters (example data and R code are provided). In a single figure, the COSS presents summary data for decision makers to determine the sample size that optimizes research funding given their operating characteristics. The COSS also presents variation in the optimal sample size given variability or uncertainty in VOI parameters. The COSS represents an efficient and additional approach for summarizing results from a VOI analysis.

Citing Articles

Value of Information Analysis: Are We There Yet?.

Tuffaha H Pharmacoecon Open. 2020; 5(2):139-141.

PMID: 32780267 PMC: 8160067. DOI: 10.1007/s41669-020-00227-6.


Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods.

Kunst N, Wilson E, Glynn D, Alarid-Escudero F, Baio G, Brennan A Value Health. 2020; 23(6):734-742.

PMID: 32540231 PMC: 8183576. DOI: 10.1016/j.jval.2020.02.010.


Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Heath A, Kunst N, Jackson C, Strong M, Alarid-Escudero F, Goldhaber-Fiebert J Med Decis Making. 2020; 40(3):314-326.

PMID: 32297840 PMC: 7968749. DOI: 10.1177/0272989X20912402.


A Need for Change! A Coding Framework for Improving Transparency in Decision Modeling.

Alarid-Escudero F, Krijkamp E, Pechlivanoglou P, Jalal H, Kao S, Yang A Pharmacoeconomics. 2019; 37(11):1329-1339.

PMID: 31549359 PMC: 6871515. DOI: 10.1007/s40273-019-00837-x.

References
1.
Eckermann S, Willan A . Expected value of information and decision making in HTA. Health Econ. 2006; 16(2):195-209. DOI: 10.1002/hec.1161. View

2.
Willan A, Kowgier M . Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods. Clin Trials. 2008; 5(4):289-300. DOI: 10.1177/1740774508093981. View

3.
Madan J, Ades A, Price M, Maitland K, Jemutai J, Revill P . Strategies for efficient computation of the expected value of partial perfect information. Med Decis Making. 2014; 34(3):327-42. PMC: 4948652. DOI: 10.1177/0272989X13514774. View

4.
Tuffaha H, Gordon L, Scuffham P . Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions. MDM Policy Pract. 2018; 1(1):2381468316642238. PMC: 6125050. DOI: 10.1177/2381468316642238. View

5.
Kearns B, Chilcott J, Whyte S, Preston L, Sadler S . Cost-effectiveness of screening for ovarian cancer amongst postmenopausal women: a model-based economic evaluation. BMC Med. 2016; 14(1):200. PMC: 5139096. DOI: 10.1186/s12916-016-0743-y. View